Beth Israel Deaconess Medical Center

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

• Beth Israel Deaconess Medical Center

  Boston, Massachusetts 02215

  509 vizsgálat

• Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care

  Winchester, Massachusetts 01890

  32 vizsgálat

• Beth Israel Deaconess Medical Center (BIDMC)

  Boston, Massachusetts 02215

  22 vizsgálat

• Beth Israel Deaconess Med Ctr

  Boston, Massachusetts 02215

  7 vizsgálat

• Beth Israel Deaconess Med Center

  Boston, Massachusetts 02215

  5 vizsgálat

• Beth Israel Deaconess Medical Center, Inc.

  Boston, Massachusetts 02215

  4 vizsgálat

• Beth Israel Deaconess Medical Center, Harvard Medical School

  Boston, Massachusetts 02215

  3 vizsgálat

  • NCT04619004HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

  • NCT02818972RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers

  • NCT00756665Prostate Active Surveillance Study

    Contact: Gabriela NietoBlanco

• Beth Israel Deaconess Medical Center - 330 Brookline Ave

  Boston, Massachusetts 02115

  2 vizsgálat

  • NCT04129502TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  • NCT03301506Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

• Beth Israel Deaconess Medical Center - Arnold Pain Management

  Brookline, Massachusetts 02115

  2 vizsgálat

  • NCT06047444A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  • NCT06047457A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

• Beth Israel Deaconess Medical Center - Clinical Research Center

  Boston, Massachusetts 02215

  2 vizsgálat

  • NCT05393232Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension

  • NCT05121337Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

• Beth Israel Deaconess Medical Center - Nephrology

  Boston, Massachusetts 02215

  2 vizsgálat

  • NCT07161037Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  • NCT06747572Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

• Beth Israel Deaconess Medical Centre

  Boston, Massachusetts 02115

  2 vizsgálat

  • NCT05335850Yoga for Mental Health in Parkinson's Patients

  • NCT05139979Yogic Breathing and Guided Meditation for Long Covid Symptoms

• 8400998 - Beth Israel Deaconess Medical Center

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03473223Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

• Beth Israel Deaconess Medical Center - 110 Francis St- Site Number : 8400013

  Boston, Massachusetts 02215-5563

  1 vizsgálat

  • NCT06028230A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

• Beth Israel Deaconess Medical Center / BIDMC VCRS (Site #32077)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07801456A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV

• Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07225569A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

• Beth Israel Deaconess Medical Center - Boston- Site Number : 8400005

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06356571A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

• Beth Israel Deaconess Medical Center - Boston- Site Number : 8401041

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06141473Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

• Beth Israel Deaconess Medical Center (Data Collection Only)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07303894A Study of Isoquercetin in People With Ovarian Cancer

    Contact: Robert Flaumenhaft, MD, PhD

• Beth Israel Deaconess Medical Center - Dermatology

  Boston, Massachusetts 02115

  1 vizsgálat

  • NCT05656911A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

• Beth Israel Deaconess Medical Center - Division of Hematology/Oncology

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06850623Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

    Contact: Selma Sinanovic Study Coordinator

• Beth Israel Deaconess Medical Center/East

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03915951An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

• Beth Israel Deaconess Medical Center,East Campus Research Pharmacy

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04389632A Study of Sigvotatug Vedotin in Advanced Solid Tumors

• Beth Israel Deaconess Medical Center /ID# 200545

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT03568318A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

• Beth Israel Deaconess Medical Center /ID# 201155

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT02993523A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

• Beth Israel Deaconess Medical Center /ID# 208124

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT03539536Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

• Beth Israel Deaconess Medical Center /ID# 210904

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT03314181A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

• Beth Israel Deaconess Medical Center /ID# 218149

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04295538Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

• Beth Israel Deaconess Medical Center /ID# 222505

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04451772A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

• Beth Israel Deaconess Medical Center /ID# 224261

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

• Beth Israel Deaconess Medical Center /ID# 225069

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04401748Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

• Beth Israel Deaconess Medical Center /ID# 228094

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04524611Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

• Beth Israel Deaconess Medical Center /ID# 228214

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04686136A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

• Beth Israel Deaconess Medical Center /ID# 240683

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05139602A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

• Beth Israel Deaconess Medical Center /ID# 241800

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05216263Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

• Beth Israel Deaconess Medical Center /ID# 248651

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05451810A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

• Beth Israel Deaconess Medical Center /ID# 249302

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05753501Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

• Beth Israel Deaconess Medical Center /ID# 251212

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05601882A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

• Beth Israel Deaconess Medical Center /ID# 252009

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

    Contact: Nicole Director Clinical Operations

• Beth Israel Deaconess Medical Center /ID# 253811

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT05889182A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

• Beth Israel Deaconess Medical Center /ID# 263703

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06389136A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

• Beth Israel Deaconess Medical Center /ID# 263709

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06468228A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

• Beth Israel Deaconess Medical Center /ID# 271535

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06158841Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

• Beth Israel Deaconess Medical Center /ID# 285204

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07728188A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

• Beth Israel Deaconess Medical Center - Liver Center

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04849728A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

• Beth Israel Deaconess Medical Center, Liver Research Center

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06447168A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

• Beth Israel Deaconess Medical Center - Oncology

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT05526248A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

• Beth Israel Deaconess Medical Center - Rheumatology /ID# 255029

  Boston, Massachusetts 02149-4903

  1 vizsgálat

  • NCT05814627Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

• Beth Israel Deaconess Medical Center (Site 0043)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06925737A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    Contact: Study Coordinator

• Beth Israel Deaconess Medical Center (Site 0044)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06956235Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

• Beth Israel Deaconess Medical Center (Site 0070)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03615326Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

• Beth Israel Deaconess Medical Center (Site 0089)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04736706A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

• Beth Israel Deaconess Medical Center (Site 0139)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07489495A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

    Contact: Study Coordinator

• Beth Israel Deaconess Medical Center (Site 0141)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03553836Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

• Beth Israel Deaconess Medical Center (Site 0161)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06890884A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

    Contact: Study Coordinator

• Beth Israel Deaconess Medical Center (Site 0716)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03713593Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

• Beth Israel Deaconess Medical Center (Site 1002)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04846920A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

• Beth Israel Deaconess Medical Center (Site #: 1004)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT05217628An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

• Beth Israel Deaconess Medical Center (Site 1501)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04195750A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

• Beth Israel Deaconess Medical Center (Site 1957)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT05933577A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

• Beth Israel Deaconess Medical Center (Site #211)

  Boston, Massachusetts 02215-5400

  1 vizsgálat

  • NCT07432958A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    Contact: Annie Blobaum, Ph.D.

• Beth Israel Deaconess Medical Center - Site #337

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

• Beth Israel Deaconess Medical Center (Site ID: 32077)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06557785A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV

• Beth Israel Deaconess Medical Center- Site Number : 1099

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03395210A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

• Beth Israel Deaconess Medical Center Site Number : 8400006

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT06118099Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

• Beth Israel Deaconess Medical Center Site Number: 8400019

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT07007962Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

• Beth Israel Deaconess Medical Centre, Harvard Medical School

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT04280029SELUTION SLR™ 014 In-stent Restenosis

• Beth Israel Deaconess Medical Ctr. (Site 0033)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03867084Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

• Beth Israel Deaconess Medical Ctr. (Site 0044)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03142334Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

• Beth Israel Deaconess Medical Ctr. (Site 0093)

  Boston, Massachusetts 02215

  1 vizsgálat

  • NCT03834519Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

• Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center

  Boston, Massachusetts 02115

  1 vizsgálat

  • NCT04812366Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

    Contact: Daniella Furtado

• Harvard Medical School - Beth Israel Deaconess Medical Center (BIDMC) - West Campus

  Boston, Massachusetts 02215-5321

  1 vizsgálat

  • NCT06706622A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

• Beth Israel Deaconess Medical Center / BIDMC VCRS (Site ID: 32077)

  Boston, Massachusetts 02115